跳至主要内容
临床试验/CTRI/2022/08/044613
CTRI/2022/08/044613暂停未知

A Prospective PlaceboControlled Randomized ClinicalStudy Of Tofacitinib As AnAdjunct to corticosteroids inAcute Severe Ulcerative Colitis

Dr Ajit Sood0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
暂停
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients with acute severe ulcerative colitis (defined by Truelove
  • Witts Criteria)
  • 2. Subject must be at least 18 years of age.
  • 3. Subjects who are willing and able to comply with treatment plan,
  • laboratory tests, daily bowel movement diary call, and other study
  • procedures.
  • 4. Subjects who are willing to provide a written informed consent.

排除标准

  • 1. Presence of indeterminate colitis, microscopic colitis, ischemic
  • colitis, infectious colitis, or clinical findings suggestive of Crohnâ??s
  • 2. Subjects displaying clinical signs of fulminant colitis or toxic
  • 3. Subjects infected with human immunodeficiency virus (HIV) or
  • hepatitis B or C viruses
  • 4. Subjects who have been vaccinated with live or attenuated vaccine
  • within 6 weeks of baseline or scheduled to receive these vaccines
  • during study period or within 6 weeks after last dose of study
  • 5. Subjects with malignancies or a history of malignancies, with the
  • exception of adequately treated or excised non-metastatic basal cell
  • or squamous cell cancer of the skin.
  • 6. Subjects with current or recent history of severe, progressive, or
  • uncontrolled renal, hepatic, hematological, gastrointestinal,
  • metabolic, endocrine, pulmonary, cardiac, neurological disease.
  • 7. Pregnant females

研究者

发起方
Dr Ajit Sood

相似试验

进行中(未招募)
1 期
Clinical study in adults and young patients with Primary Sclerosing Cholangitis treated with oral vancomycin or placeboPrimary Sclerosing Cholangitis
CTIS2023-507425-42-00niversity Of Milano Bicocca84
进行中(未招募)
1 期
A study to quantify any differences in blood pressure control and kidney function after oral administration of amlodipine (a drug to treat high blood pressure) and celecoxib (a non steroidal anti inflammatory drug) given together or amlodipine alone, once daily, in adult patients with high blood pressure.Hypertension
EUCTR2016-002214-47-GBKitov Pharmaceuticals Ltd105
进行中(未招募)
1 期
A study to quantify any differences in blood pressure control after oral administration of amlodipine (a drug to treat high blood pressure) and celecoxib (a non steroidal anti inflammatory drug) given together or alone, once daily, in adult patients with newly diagnosed hypertension.Hypertension
EUCTR2013-005381-19-GBKitov Pharmaceuticals Ltd
进行中(未招募)
3 期
Evaluate the Efficacy and Safety of Dose for cholesterolTM (Dietary supplement) and assess the effect of Dose for CholesterolTM on Cholesterol levels in healthy adults.
CTRI/2024/05/066945EETHO BRANDS INC
已完成
2 期
A randomised placebo-controlled study of lovastatin in children with neurofibromatosis type 1Neurofibromatosis type 1eurofibromatosis type 1Neuropsychological impairmentHuman Genetics and Inherited Disorders - Other human genetics and inherited disorders
ACTRN12607000560493Prof Kathryn North142